Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
PT. Kimia Farma Apotek works in Pharmaceutical Manufacturing, out of Central Jakarta, Jakarta Capital Region. Ownership is privately held; it publishes at kimiafarmaapotek.co.id. It holds one address on record, all in Indonesia. The record counts 3,458 people. Tagged pharmacy, healthcare and clinics. The latest round on record is Series unknown at US$119.2M. The record links nine similar brands, most of them in Pharmaceutical Manufacturing.
kimiafarmaapotek.co.id LinkedIn
PT. Kimia Farma Apotek is the current largest primary care provider in Indonesia. We deliver the best primary care across archipelago trough our various services. With 700+ pharmacies, 300+ clinics, and 40+ diagnostic centers, we aim to be the number one partner in healthcare for Indonesians.
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
| Rounds | 1 |
|---|---|
| Axis | 2003 to 2026 |
| Series unknown · 13 Dec 2022 | US$ 119.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 3,458 counted staff profiles at January 2026, inside the self-reported 1,001–5,000 band.
One address on record, Indonesia only. Primary: Jalan Budi Utomo No. 1, Central Jakarta, Jakarta Capital Region 10710.
One round. Latest 13 December 2022: Series unknown, US$119,200,000, investors Indonesia Investment authority and Silk Road Fund.
Eight tags on the brand's own list, among them pharmacy, healthcare and clinics.
Nine peer profiles on record: PT. KIMIA FARMA, TBK and Novell Pharmaceutical Laboratories.